INGN Q2 2025 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$92M+4.0% YoY

Gross Profit

$41M44.8% margin

Operating Income

-$6M-6.6% margin

Net Income

-$4M-4.5% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+12.1%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$480,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$312M

Total Liabilities

$113M

Stockholders' Equity

$199M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92M	$89M	+4.0%
Gross Profit	$41M	$43M	-3.3%
Operating Income	-$6M	-$7M	+13.2%
Net Income	-$4M	-$6M	+25.7%

Geographic Segments

UNITED STATES

$56M61%

Non-US

$36M39%